eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | diffuse large b-cell lymphoma |
| Comorbidity | C0024301|follicular lymphoma |
| Sentences | 6 |
| PubMedID- 22641292 | The outcome after allogeneic hematopoietic stem cell transplantation (allo-hct) for diffuse large b-cell lymphoma (dlbcl) associated with follicular lymphoma (fl), which includes dlbcl with pre- or co-existing fl, remains controversial, and few previous reports have compared the outcomes after allo-hct for fl, dlbcl associated with fl, and de novo dlbcl. |
| PubMedID- 24491027 | We retrospectively evaluated the safety and efficacy of high-dose chemotherapy consisting of cyclophosphamide, etoposide and ranimustine (cem) with autologous peripheral blood stem cell transplant (pbsct) in 55 adult patients with relapsed or high-risk de novo diffuse large b-cell lymphoma (dlbcl) or dlbcl associated with follicular lymphoma. |
| PubMedID- 25803724 | In regard to the remaining 2 patients, 1 patient had a recurrent intravascular cutaneous follicular lymphoma in the context of a history of diffuse large b-cell lymphoma. |
| PubMedID- 26475474 | Previous related studies showed increased expression of the p38 mapk transcript and protein in a subset of dlbcl arising from follicular lymphomas [33]. |
| PubMedID- 25016003 | The overall response rate was 30%, including responses in follicular lymphoma (4 of 9) and dlbcl (2 of 5). |
| PubMedID- 24955711 | follicular lymphoma with progression to diffuse large b-cell lymphoma and concurrent cd5-negative mantle cell lymphoma-3 entities in a lymph node. |
Page: 1